{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skull&page=11", "query": { "condition": "Skull", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 793, "total_pages": 80, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skull&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skull&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-26T17:27:14.459Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07225101", "title": "Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Wound Closure", "Brain Tumor Adult", "Spine", "Neurovascular", "Hemorrhagic Stroke, Intracerebral", "Traumatic Brain Injury" ], "interventions": [ { "name": "STRATAFIX PDS and Monocryl suture", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2025-11-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2025-11-05", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Lansing, Michigan", "locations": [ { "city": "Lansing", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07225101" }, { "nct_id": "NCT03840928", "title": "PatientSpot Formerly Known as ArthritisPower", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Fibromyalgia", "Gout", "Crohn Disease", "Juvenile Idiopathic Arthritis", "Lupus Erythematosus", "Myositis", "Osteoarthritis", "Osteoporosis", "Psoriasis", "Psoriatic Arthritis", "Scleroderma", "Dermatomyositis", "Inflammatory Bowel Diseases", "Polymyositis", "Axial Spondyloarthritis", "Diffuse Idiopathic Skeletal Hyperostosis", "Polymyalgia Rheumatica", "Giant Cell Arteritis", "Temporal Arteritis", "Wegener", "Relapsing Polychondritis", "Undifferentiated Connective Tissue Disease", "Spinal Cord Injuries", "Alzheimer Disease", "Amyotrophic Lateral Sclerosis", "Ataxia", "Bell Palsy", "Brain Tumor", "Cerebral Aneurysm", "Epilepsy", "Guillain-Barre Syndrome", "Headache", "Head Injury", "Hydrocephalus", "Lumbar Disc Disease", "Meningitis", "Multiple Sclerosis", "Muscular Dystrophy", "Neurocutaneous Syndromes", "Parkinson Disease", "Stroke", "Cluster Headache", "Tension-Type Headache", "Chronic Obstructive Pulmonary Disease", "Asthma", "Lung Cancer", "Cystic Fibrosis", "Sleep Apnea", "Eczema", "Alopecia", "Chronic Inflammation", "Unstable Angina", "Heart Attack", "Heart Failure", "Arrythmia", "Valve Heart Disease", "High Blood Pressure", "Congenital Heart Disease", "Peripheral Arterial Disease", "Diabetes", "Chronic Liver Disease", "Obesity" ], "interventions": [], "intervention_types": [], "sponsor": "Global Healthy Living Foundation", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 40000, "start_date": "2015-04-01", "completion_date": "2025-03-01", "has_results": false, "last_update_posted_date": "2023-12-13", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Upper Nyack, New York", "locations": [ { "city": "Upper Nyack", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03840928" }, { "nct_id": "NCT03391765", "title": "An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Progressive Supranuclear Palsy (PSP)" ], "interventions": [ { "name": "ABBV-8E12", "type": "DRUG" }, { "name": "Placebo solution for IV infusion on Day 15", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 142, "start_date": "2018-01-24", "completion_date": "2019-12-13", "has_results": true, "last_update_posted_date": "2021-02-03", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Beverly Hills, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03391765" }, { "nct_id": "NCT07832266", "title": "Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cranial Nerve Injury", "Oropharyngeal Cancer" ], "interventions": [ { "name": "Prednisone", "type": "DRUG" }, { "name": "Ajovy", "type": "DRUG" }, { "name": "Manual Therapy", "type": "OTHER" }, { "name": "IOPI device", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2027-03-01", "completion_date": "2032-09-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07832266" }, { "nct_id": "NCT01759602", "title": "C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuromyelitis Optica" ], "interventions": [ { "name": "C1-esterase inhibitor (Cinryze)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Michael Levy", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2013-01", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2014-07-18", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01759602" }, { "nct_id": "NCT04660539", "title": "A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neuromyelitis Optica Spectrum Disorder" ], "interventions": [ { "name": "satralizumab", "type": "DRUG" }, { "name": "azathioprine (AZA)", "type": "DRUG" }, { "name": "mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "oral corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 119, "start_date": "2021-03-02", "completion_date": "2024-05-28", "has_results": true, "last_update_posted_date": "2024-12-27", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Miami, Florida • Columbus, Georgia + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Miami", "state": "Florida" }, { "city": "Columbus", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Northbrook", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04660539" }, { "nct_id": "NCT06317701", "title": "Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "Hypoglossal Nerve Stimulation (HGNS)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2024-04-04", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT06317701" }, { "nct_id": "NCT04283981", "title": "Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Mandibular Fractures" ], "interventions": [ { "name": "Control group without use of VSP", "type": "DEVICE" }, { "name": "Treatment Group with use of VSP", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2021-01-24", "completion_date": "2022-11-10", "has_results": true, "last_update_posted_date": "2024-06-20", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04283981" }, { "nct_id": "NCT06647641", "title": "The CurePSP Genetics Program", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "PSP", "PSP - Progressive Supranuclear Palsy", "Corticobasal Syndrome", "Corticobasal Syndrome(CBS)", "Corticobasal Degeneration Syndrome", "Corticobasal Degeneration", "Corticobasal Degeneration (CBD)", "Corticobasal Syndrome (CBS)", "MSA", "MSA - Multiple System Atrophy", "MSA-C", "Multiple System Atrophy", "Multiple System Atrophy (MSA) With Orthostatic Hypotension", "Multiple System Atrophy - Cerebellar Subtype (MSA-C)", "Multiple System Atrophy - Parkinsonian Subtype (MSA-P)", "Multiple System Atrophy, Cerebellar Type", "Multiple System Atrophy, Parkinsonian Type", "Progressive Supranuclear Palsy", "Progressive Supranuclear Palsy(PSP)", "Progressive Supranuclear Palsy (PSP)" ], "interventions": [ { "name": "Whole genome sequencing will be performed at the NIH", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 1000, "start_date": "2024-10-08", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06647641" }, { "nct_id": "NCT05771051", "title": "Australian University of California San Francisco (UCSF) Concussion in Athletes (AUSSIE-2)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Concussion, Mild" ], "interventions": [ { "name": "Headpulse measurements", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2022-03-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2023-03-16", "last_synced_at": "2026-10-26T17:27:14.459Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05771051" } ] }